According to Essa Pharma latest financial reports the cash on hand of EPIX is $148.08M, an decrease of -11.46% to 2022. At the end of 2022 company had $167.24M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $148.08M | -11.46% |
2022 | $167.24M | -14.21% |
2021 | $194.93M | 148.85% |
2020 | $78.33M | 46.90% |
2019 | $53.32M | 259.58% |
2018 | $14.83M | - |